3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress

When

2020年5月18-19日

Where

愛爾蘭,都柏林
Castleknock Hotel, Castleknock, Dublin 15

3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress
-第3屆 全球生物製程、生物分析、ATMP製造學會-
日期:2020年5月18-19日
地點:愛爾蘭,都柏林,Castleknock Hotel
Choose your language
Chinese
Japanese
Korean
English

3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress

探索加速次世代生物製劑高效生產的新技術與製造策略

學會為期2天、安排了超過30場演講,生物醫藥製造領域主要研究人員將分享針對次世代生物製劑與尖端治療藥物之最新技術和製造策略。會議著重生物製程領域的重要課題,以及在維持高品質的同時提升治療藥生產效率與產量的創新解決方案,並討論連續生物製程、單次使用技術、資料完整性、PAT、工業4.0等議題。此外也將聚焦細胞與基因療法藥物製造,討論這些複合產品相關規範與製造面挑戰。

“There was a broad range of topics with high-level of content” Delegate – Medical Solutions Business
“I appreciated the subject matter of presentations and diversity of presenters. The regulatory track was very good.” Delegate Pharmaceutical Company
The meeting had a really good overall feel to it, and the range of speakers was interesting with some great insight into the challenges that face the industry.” Speaker Pharma company
“This was a great opportunity to network with other participants and with the sponsors. Also the content of the presentations was excellent.” Sponsor

2020年的主要演講者 – 演講者名單

議程

第1天
The Biomanufacturing Strategies to Meet the Needs of Multiple Modalities in Biologics
Judy Chou, Global Head of Biotech, Bayer Pharmaceuticals
Perspectives of Vaccine Development and Manufacture
Tony D’Amore, Vice President, Product R&D, Sanofi Pasteur
High Cell Concentration Banking for Seed Train Reduction on Fluoropolymer Single-Use Bag
Jonathan Cartoux, EMEA Field Application Engineer, Entegris
Poster Presentations
Track 1: Next-Generation Technologies & Novel Manufacturing Strategies Track 2: Quality Control, Bioanalytics & the Regulatory Landscape
Digital Design and Optimization of Bioprocessing Operations
Christian Witz, Head of the Computational Bioprocess Engineering Group, Institute for Process and Particle Engineering, Graz University of Technology
Biologics & Regulation: The Next Generation
David Murray, Pharmaceutical (Quality) Assessor - Biologics, HPRA
Industrialisation and scale up: lessons learnt
Amir Goudarzi, Head of Process Engineering, BioPilot Plant, AstraZeneca
Regulatory challenges of ATMP manufacturing
Baerbel Grossman, Associate Director, Global Regulatory Affairs CMC, Sanofi
Solution Provider Presentation – Securecell AG Solution Provider Presentation – Gyros Protein Technologies
Lunch
A brand new Monoclonal Antibody Plant – Tevas footprint for large scale Biotech Production
Christiane Bardoff, Director Upstream Processing and Automation/IT, Teva Biologics Operations, Teva
Attribute-Focused Methods for Building Robust Control
Strategy
Tapan Das, Director, Analytical Development, Bristol-Myers Squibb
Real-time monitoring of cell viability during a bioprocess
Michael Butler, Emeritus Professor and Principal Investigator in Cell Technology, NIBRT
An Integrated Multi-Omics (BTI-Biomodel) Platform Includes New Software for Automated Detailed Glycan Analysis to Aid QBD and Process Control
Pauline Rudd, Visiting Investigator, Bioprocessing Technology Institute, A*Star Institute
Opening the "Black Box": An Innovative kLa Measurement Procedure for Bioreactor Characterization & Optimization.
Thomas Maischiberger, Process Engineer & Project Development, ZETA GmbH
Solution Provider Presentation
Poster Presentations
Solution Provider Presentation – TQS Integration Solution Provider Presentation
PAT and process modelling
Caitlin O'Mahony Hartnett, Scientist BioTherapeutics
Development, Janssen
Roundtables
1. Legal Perspective for Cell and Gene Therapies
Lisa Kinsella, Head Legal NTO Biologics, Cell & Gene,
Novartis (Reserved)
2. Control Strategy
Cathrina Houlihan, Site Control Strategy Lead, New
Product Industrialisation & Devices, Sanofi (Reserved)
Networking Drinks Reception
第2天
Topic: Transformational Companies in Gene Therapy
Rahul Singhvi, Flagship Pioneering
Solution Provider Presentation – Sciex
Track 1: Next-Generation Technologies & Novel
Manufacturing Strategies
Track 2: Manufacturing Cell & Gene Therapies

Acceleration and market forces
Corne Stroop, Director Biologics & Vaccine Analysis, Merck (Reserved)
Lentiviral Vector Manufacturing and analytics – Opportunities, Challenges and Ways Forward
Alice Laures, Team Leader, Future Analytical and Control Technologies, GSK
Paul Carter, Scientific Leader, Downstream Process Development, Cell and Gene Therapy, GSK
Poster Presentations
Case study
Matthew Cheeks, Director of Biopharmaceutical Development, AstraZeneca
New developments and challenges for the analysis and
characterization of AAV's
Dennis Ungan, Scientist II, NIBR NBC CFB Characterization Group,
Novartis (Reserved)
Development and manufacturing of immuno-oncology products through global CDMOs
Vadim Klyushnichenko, Vice President, Pharmaceutical Development and Quality, Calibr, Scripps Insititute
Capillary electrophoresis and liquid chromatography for
characterisation of AAV vectors
Franz Schnetzinger, Director Quality Control & CMC Analytical Development, Gyroscope Therapeutics
Solution Provider Presentation – Labware Ltd Solupore®- Next-Generation Non-Viral Cell Engineering
Shirley O’Dea, Chief Scientific Officer, Avectas
Lunch
Case study
Miriam McCarthy, Head of Technical Services CMO EU, Takeda
Optimisation of viral vector upstream process: Case study
Beata Adamiak, Senior Manager, Process Sciences, Allergan
Integrated digital twin solution for the bioprocess validation life cycle
Christoph Herwig, Founder of Exputec & Full Professor for Biochemical Engineering at TU Wien, Austria (Reserved)
A practical look at Analytical methods across all stages of ATMPs
Francesca Rossetti, Analytical Methods Development Manager, MolMed
Interfacing machine learning and process science for next level process development
Moritz Von Stosch, Senior Manager, Process Systems Biology & Engineering Center of Excellence, GSK Biologicals
ATMP Manufacturing in CCMI- the story so far
Aoife Duffy, Production, Regulatory Affairs and Training Manager, CCMI
Case study
Cyril Boucher, Manager, Drug Substance Clinical Operations, Merck (Reserved)
Automation and Serialization Compliance
Isaac Erickson, Director of Bioprocess Manufacturing. DiscGenics
Conference Ends

* 活動內容有可能不事先告知作更動及調整。

建議參加學會的理由

2020年學會安排了生物醫藥品製造領域領導研究人員演講,將能深入了解最新製造法與技術。

  • 了解滿足生物製劑各種模態需求的生物製造策略。
  • 了解高性能模擬演算法如何優化生物製程運作。
  • 了解監管機構期望與挑戰。
  • 探索未來如何持續發展疫苗開發與生產。
  • 找出可用於開發病毒載體生產的最新分析技術。
  • 為成功推動計畫的CMO選擇程序與基準訂定。

演講者

2020年的演講者

聆聽生物製程與製程分析各領域專家演講

議程概要
  • 監管面課題
  • 工業4.0:挑戰與實施
  • 單次使用技術
  • 整合的連續生物製造
  • 製程模型與分析技術
  • 因應GMP、PAT、CMC準則
  • 蛋白質表徵分析與監測
  • 生物化驗與生物活性判定
  • 細胞與基因治療藥物的製造
學會亮點
  • 30多場產業界及學術界研究人員與企業代表演講。
  • 超過7小時的各種交流活動。
  • 各領域專家主持的團體討論。
  • 進一步擴充的各類組織高階主管小組討論。
  • 領先企業參展、充滿活力的展示會。
  • 首日傍晚安排了招待會。

 

* 活動內容有可能不事先告知作更動及調整。

贊助商

2020年的學會贊助商

贊助商名單

地點

Castleknock Hotel, Castleknock, Dublin 15

Porterstown Rd, Diswellstown Dublin, WNR7, Ireland

海報發表

海報展示不僅將在休息時間進行,更將在分組會議期間進行。企業和研究機關的研究人員所製作的所有海報,經學會事務局認證之後,將會張貼在會場的指定區域。

此外會議結束後,將向所有與會者分發彙整了海報發表主旨的電子書,將海報以pdf格式發布(僅限有意願同意發佈者)。

對於任何尋求投資或就業機會,或者只想向有類似想法的研究人員或從事相同主題的研究小組展現其研究成果的人,海報發表也是一個能讓您獲得會場內大量關注的寶貴機會。

要進行海報展示,需要報名參加會議。可張貼海報的空間有限,並且以報名先後順序接受申請審查,薦請大家即早報名以免向隅。

海報發表競賽 - 報名申請期限:2020年5月1日

海報發表的申請方法

請填好專用表格(可從下面的鏈接下載)並在2020年3月20日之前提交。即使在截止日期前,也有可能因空間已滿而停止受理報名,敬請即早申請。如有任何疑問,請洽詢聯絡處。

學會贊助商

2020年的學會贊助商

媒體合作夥伴

  • Bentham Science
  • Biobased Press
  • Biocompare
  • BioMall
  • BiopharmaTrend
  • Biovox
  • Cell Therapy News
  • EIN Presswire
  • Future of Manufacturing
  • Global Information
  • Greater Copenhagen Life Science
  • Hospitals Management
  • The Medicine Maker
  • Pharmaceutical Tech
  • Pharma Journalist
  • PharmaVOICE
  • RxNet
  • SciDoc Publishers

募集贊助商

可以提前預約20分鐘的個人會議時段

贊助商和參展商可以在主要會議的分組討論期間提前預約各20分鐘的個人會議時段,與他們希望會晤的對象會面。會期中,Global Engage團隊會駐守會場,以幫助你可如時進行會談。

主要會議前後的研討會

在主要會議前後,您可針對對特定主題感興趣的人士召開半天或全天的研討會。Global Engage將為研討會進行相關的宣傳活動,確保有足夠的參與者。

學會開幕前的行銷和品牌宣傳

您可利用Global Engage的資料庫展開行銷。此外您還可以透過張貼海報,贊助休息和午餐會,招待會,海報單元來提高品牌知名度,我們同時更準備了在分發給與會者的掛繩或學會資料袋上印刷標誌來宣傳這樣的方案。

參展

展覽期間,所有與會者都將能夠在會場設置的專用展覽區中展示其技術和產品。展覽區同時也是休息、午餐和第一天晚上舉行招待會的會場。

演講

演講的形態

  • 30分種的演講
  • 以主持人或小組成員的身份參加30分鐘的小組討論
  • 會議議程中的一小時研討會

募集贊助商

請洽詢GII日商環球訊息有限公司以獲取詳細信息。

包括簽證等各種海關所需文件,以及展示用品的通關手續皆由展商企業各自負責。

展示相關的安排(企業介紹、公司商標、提供與會者目錄中的展商資訊登錄、展示空間的裝潢、用品訂購、展示用品的擺設搬運、展示空間的文件申請、保險等)請直接與主辦方連繫。

旅遊相關疑問(住宿、機票)、當地翻譯人員、飛行與意外保險等問題,將有另外的專門業者分別提供服務。

關於第3屆Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress的贊助商詳情請洽詢聯絡處。

 
免費電子郵件通知服務